Literature DB >> 19662370

Effects of 5-Aza-CdR on the proliferation of human breast cancer cell line MCF-7 and on the expression of Apaf-1 gene.

Huihua Xiong1, Hong Qiu, Liang Zhuang, Hua Xiong, Rui Jiang, Yuan Chen.   

Abstract

Hypermethylation in the promoter region of tumor suppressor genes is a common mechanism of gene silencing, which tends to occur in cancer. The effects of 5-Aza-2'-deoxycytidine (5-Aza-CdR), a specific DNA methyltransferase inhibitor, on the cell proliferation of human breast cancer cell line MCF-7 and on the expression of Apaf-1 gene were investigated. Human MCF-7 cells were incubated with increasing concentrations of 5-Aza-CdR for 12 to 120 h. The growth inhibition rates of MCF-7 cells were detected by MTT assay. Changes of cell cycle distribution and apoptotic rates of MCF-7 cells were determined by flow cytometry. The expressions of DNA methyltransferase 3b mRNA and Apaf-1 mRNA were measured by reverse transcription polymerase chain reaction (RT-PCR). Meanwhile, the expression of Apaf-1 protein was detected by Western blotting. The results showed that 5-Aza-CdR significantly inhibited the growth of MCF-7 cells and the growth inhibition rate of MCF-7 cells was significantly enhanced with the concentration of 5-Aza-CdR and the action time. Flow cytometry indicated that 5-Aza-CdR could significantly induce G(1)/S cell cycle arrest and increase the apoptosis rate of MCF-7 cells. The mRNA and protein expressions of Apaf-1 were up-regulated in MCF-7 cells treated with 5-Aza-CdR, which was accompanied by down-regulation of DNA methyltransferase 3b mRNA. It is concluded that 5-Aza-CdR might retard the growth of tumor cells and promote the apoptosis of MCF-7 breast cancer cells by inhibiting the expression of DNA methyltransferase 3b and re-activating the Apaf-1 gene expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19662370     DOI: 10.1007/s11596-009-0421-9

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  23 in total

Review 1.  Epigenetic therapy of leukemia: An update.

Authors:  Nitin Jain; Adriana Rossi; Guillermo Garcia-Manero
Journal:  Int J Biochem Cell Biol       Date:  2008-10-17       Impact factor: 5.085

2.  Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics.

Authors:  D H Jeong; M Y Youm; Y N Kim; K B Lee; M S Sung; H K Yoon; K T Kim
Journal:  Int J Gynecol Cancer       Date:  2006 May-Jun       Impact factor: 3.437

3.  Upregulation of neuronal nitric oxide synthase mRNA and protein in adrenal medulla of water-deprived rats.

Authors:  Feng-Jie Lai; Shiue-Shin Huang; Ming-Chia Hsieh; Shih-Chie Hsin; Chin-Han Wu; Ya-Chieh Hsin; Shyi-Jang Shin
Journal:  J Histochem Cytochem       Date:  2005-01       Impact factor: 2.479

4.  Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy.

Authors:  Yeonjoo Jung; Jinah Park; Tai Young Kim; Jung-Hyun Park; Hyun-Soon Jong; Seock-Ah Im; Keith D Robertson; Yung-Jue Bang; Tae-You Kim
Journal:  J Mol Med (Berl)       Date:  2007-06-15       Impact factor: 4.599

5.  Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer.

Authors:  Brandon J Metge; Andra R Frost; Judy A King; Donna Lynn Dyess; Danny R Welch; Rajeev S Samant; Lalita A Shevde
Journal:  Clin Exp Metastasis       Date:  2008-06-20       Impact factor: 5.150

6.  Effects of 5-Aza-CdR on cell proliferation of breast cancer cell line MDA-MB-435S and expression of maspin gene.

Authors:  Bo Zhang; Tao Huang; Ke Liu; Jianying Chen; Guobin Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-10

7.  mRNA expression profiles of methylated APAF-1 and DAPK-1 tumor suppressor genes uncover clear cell renal cell carcinomas with aggressive phenotype.

Authors:  F Christoph; S Hinz; C Kempkensteffen; M Schostak; M Schrader; K Miller
Journal:  J Urol       Date:  2007-10-22       Impact factor: 7.450

8.  Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma.

Authors:  Eunkyung Ko; Yujin Kim; Sung-Joo Kim; Jae-Won Joh; SangYong Song; Cheol-Keun Park; Joobae Park; Duk-Hwan Kim
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08-22       Impact factor: 4.254

9.  Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase.

Authors:  Lamia Benbrahim-Tallaa; Robert A Waterland; Anna L Dill; Mukta M Webber; Michael P Waalkes
Journal:  Environ Health Perspect       Date:  2007-10       Impact factor: 9.031

10.  SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response.

Authors:  S Cheetham; M J Tang; F Mesak; H Kennecke; D Owen; I T Tai
Journal:  Br J Cancer       Date:  2008-05-06       Impact factor: 7.640

View more
  6 in total

1.  Expression profiling after induction of demethylation in MCF-7 breast cancer cells identifies involvement of TNF-α mediated cancer pathways.

Authors:  Ju Hee Kim; Seongeun Kang; Tae Woo Kim; Lihong Yin; Ran Liu; Sun Jung Kim
Journal:  Mol Cells       Date:  2012-01-02       Impact factor: 5.034

2.  Effect of 5-aza-2'-deoxycytidine on Estrogen Receptor Alpha/Beta and DNA Methyltransferase 1 Genes Expression, Apoptosis Induction, and Cell Growth Prevention of the Colon Cancer HT 29 Cell Line.

Authors:  Masumeh Sanaei; Fraidoon Kavoosi
Journal:  Int J Prev Med       Date:  2020-09-10

Review 3.  Epigenetic Factors as Etiological Agents, Diagnostic Markers, and Therapeutic Targets for Luminal Breast Cancer.

Authors:  Nguyen Xuan Thang; Seonho Yoo; Hyeonwoo La; Hyeonji Lee; Chanhyeok Park; Kyoung Sik Park; Kwonho Hong
Journal:  Biomedicines       Date:  2022-03-23

Review 4.  Epigenetic Therapies and Biomarkers in Breast Cancer.

Authors:  Lauren Julia Brown; Joanna Achinger-Kawecka; Neil Portman; Susan Clark; Clare Stirzaker; Elgene Lim
Journal:  Cancers (Basel)       Date:  2022-01-18       Impact factor: 6.639

5.  Genome-wide screening of genes regulated by DNA methylation in colon cancer development.

Authors:  Sándor Spisák; Alexandra Kalmár; Orsolya Galamb; Barna Wichmann; Ferenc Sipos; Bálint Péterfia; István Csabai; Ilona Kovalszky; Szabolcs Semsey; Zsolt Tulassay; Béla Molnár
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

6.  Low concentrations of 5-aza-2'-deoxycytidine induce breast cancer stem cell differentiation by triggering tumor suppressor gene expression.

Authors:  Nhan Lu-Chinh Phan; Ngu Van Trinh; Phuc Van Pham
Journal:  Onco Targets Ther       Date:  2015-12-23       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.